Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System is Scopus-indexed (Q2, CiteScore 5.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1470-3203Verify ISSN ↗1752-8976Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: About US$4,150 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 57 / 179 | 68th | Q2 |
| Endocrinology | 59 / 132 | 55th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2000–present, best quartile Q2, CiteScore 5.5.
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System is Q2 in Internal Medicine (rank 57 of 179) and Q2 in Endocrinology (rank 59 of 132), by CiteScore 2025.
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.5, which places it in quartile Q2 at the 68th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.020, quartile Q2, with an H-index of 54.
The publisher lists an article processing charge of about US$4,150 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System is published by SAGE Publications Ltd. Its print ISSN is 1470-3203 and its online ISSN is 1752-8976.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System has an h-index of 59 and a 2-year mean of 1.73 citations per paper (OpenAlex). Its Scopus CiteScore is 5.5, quartile Q2. On 2-year citations it ranks #82 of 172 Scopus journals in Internal Medicine.
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System published 41 papers in 2025; its busiest recent year was 2020 with 45. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2022–2026), authors are most often from China (45.5%), India (7.5%) and Mexico (5.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 13 retracted papers are recorded (9.8 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.